Suppr超能文献

小窝蛋白-1通过NOX4/ROS/GPX4途径抑制铁死亡,从而改善非酒精性脂肪性肝病中的肝损伤。

Caveolin-1 ameliorates hepatic injury in non-alcoholic fatty liver disease by inhibiting ferroptosis via the NOX4/ROS/GPX4 pathway.

作者信息

Wu Shuai, Guo Ning, Xu Hanlin, Li Yu, Sun Tianyin, Jiang Xiangfu, Fu Dongdong, You Tingyu, Diao Shaoxi, Huang Yan, Hu Chengmu

机构信息

Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei 230032, China; Institute for Liver Diseases of Anhui Medical University, School of Pharmacy, Anhui Medical University, Hefei 230032, China; Key Laboratory of Anti-Inflammatory and Immune Medicine, Ministry of Education, Hefei 230032, China.

出版信息

Biochem Pharmacol. 2024 Dec;230(Pt 2):116594. doi: 10.1016/j.bcp.2024.116594. Epub 2024 Oct 26.

Abstract

Nonalcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver disease globally, with a complex and contentious pathogenesis. Caveolin-1 (CAV1) is an important regulator of liver function and can mitigate liver injury by scavenging reactive oxygen species (ROS). Evidence suggests that NOX4 is a source of ROS production, that oxidative stress and ferroptosis are closely related, and that both are involved in the onset and progression of NAFLD. However, whether CAV1 attenuates liver injury in NAFLD caused by high-fat diet via the NOX4/ROS/GPX4 pathway remains unclear. An in vivo fatty liver model was established by feeding mice with a high-fat diet for 16 weeks. In addition, an in vitro fatty liver model was established by incubating AML-12 cells with free fatty acids for 24 h using an in vitro culture method. In our study, it was observed that a high-fat diet induces mitochondrial damage and worsens oxidative stress in NAFLD. This diet also hinders GPX4 expression, leading to an escalation of ferroptosis and lipid accumulation. To counteract these effects, intraperitoneal administration of CSD peptide in mice attenuated the high-fat diet-induced liver mitochondrial damage and ferroptosis. Likewise, overexpression of CAV1 resulted in an increase in GPX4 expression and a reduction in levels of ROS-mediated iron metamorphosis, thus mitigating the progression of the disease. However, the effects of CAV1 on GPX4-mediated ferroptosis and lipid deposition could be reversed by CAV1 small interfering RNA (SiRNA). Finally, NOX4 inhibitor (GLX351322) treatment increased CAV1 siRNA-mediated GPX4 expression and decreased the level of ROS-mediated ferroptosis. These findings suggest a potential mechanism underlying the protective role of CAV1 against high-fat diet-induced hepatotoxicity in NAFLD, shedding new light on the interplay between CAV1, GPX4, and ferroptosis in liver pathology.

摘要

非酒精性脂肪性肝病(NAFLD)是全球最普遍的慢性肝病,其发病机制复杂且存在争议。小窝蛋白-1(CAV1)是肝功能的重要调节因子,可通过清除活性氧(ROS)减轻肝损伤。有证据表明,NOX4是ROS产生的来源,氧化应激与铁死亡密切相关,二者均参与NAFLD的发生和发展。然而,CAV1是否通过NOX4/ROS/GPX4途径减轻高脂饮食所致NAFLD的肝损伤仍不清楚。通过给小鼠喂食高脂饮食16周建立体内脂肪肝模型。此外,采用体外培养方法,用游离脂肪酸孵育AML-12细胞24小时建立体外脂肪肝模型。在我们的研究中,观察到高脂饮食会导致NAFLD中的线粒体损伤并加重氧化应激。这种饮食还会阻碍GPX4的表达,导致铁死亡和脂质蓄积加剧。为抵消这些影响,给小鼠腹腔注射CSD肽可减轻高脂饮食诱导的肝线粒体损伤和铁死亡。同样,CAV1的过表达导致GPX4表达增加,ROS介导的铁转化水平降低,从而减轻疾病进展。然而,CAV1小干扰RNA(SiRNA)可逆转CAV1对GPX4介导的铁死亡和脂质沉积的影响。最后,NOX4抑制剂(GLX351322)处理可增加CAV1 siRNA介导的GPX4表达,并降低ROS介导的铁死亡水平。这些发现提示了CAV1对NAFLD中高脂饮食诱导的肝毒性具有保护作用的潜在机制,为CAV1、GPX4和铁死亡在肝脏病理学中的相互作用提供了新的线索。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验